1-2 of 2
Malika Djeridane
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Radioimmunotherapy (RIT) of Refractory or Relapsed Hodgkin’s Lymphoma (HL) with 90 Yttrium-Labelled Antiferritin Antibody.

Didier Decaudin, MD, PhD, Rafaël Lévy, MD, François Lokiec, PD, PhD, Olivier Madar, PD, Rémi Brossel, MD, Franck Morschhauser, MD, Valentine Songeur, Malika Djeridane, Jean Kadouche, Alain Pecking, MD
Journal: Blood
Blood (2007) 110 (11): 4473.
https://doi.org/10.1182/blood.V110.11.4473.4473
Published: 2007
Journal Articles

Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation

Clinical Trials & Observations
Pierre Feugier, Eric Labouyrie, Malika Djeridane, Arash Jenabian, Viviane Dubruille, Christian Berthou, Christiane Ghandour, Bernard Desablens, Yasmine Chaït, Philippe Casassus, Vincent Delwail, Norbert Ifrah, Annick Le Mevel, Thierry Lamy, Josette Brière, Pierre Colonna, Jean-Marie Andrieu
Journal: Blood
Blood (2004) 104 (9): 2675–2681.
https://doi.org/10.1182/blood-2004-02-0567
Published: 2004